Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 sept. 2024 04h00 HE | Source: Abingworth

Abingworth appoints Robert DeBenedetto as Managing Director – Clinical Co-Development

London, UK and New York, USA, September 10, 2024 - Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ: CG), today announced the...
29 févr. 2024 07h00 HE | Source: Abingworth

Abingworth Announces a Strategic Development Financing Agreement with Gilead Sciences; Establishes Joint Steering Committee between Launch Therapeutics and Gilead Sciences

London, UK and New York, USA, February 29, 2024 - Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced a strategic...
30 oct. 2023 04h00 HE | Source: Abingworth

Abingworth raises $356 million for new Clinical Co-Development Co-Investment Fund (CCD-CIF)

Abingworth extends its capital base for late-stage clinical programs with pharma and biotech partners London, UK and New York, USA, October 30, 2023 - Abingworth, a leading international life...